New study shows that dysfunction of protective immune cells in GI tract may contribute to onset of inflammation in Crohn's disease.
The FDA expanded the approval of guselkumab (Tremfya) to include treatment of moderately to severely active Crohn's disease, ...
A research team led by Mount Sinai has uncovered mechanisms of abnormal immune cell function that may lead to Crohn's disease ...
Doctors typically treat Hirschsprung disease with surgery to remove part of the intestine. Learn about surgical procedures, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results